MRFF – Emerging Priorities and Consumer Driven Research Initiative – 2023 Post-Acute Sequelae of COVID-19 Grant Opportunity (Stream 4 Stage 2 ONLY)
The Medical Research Future Fund (MRFF) – 2023 Post-Acute Sequelae of COVID-19 Grant Opportunity will support medical research and medical innovation projects that:
- Stream 4 (Aim 3 of Research Plan):
- Stage 2 (Targeted Call for Research): establish a multidisciplinary national adaptive platform trial that accelerates assessment and implementation of therapeutic interventions (pharmacological and non-pharmacological) for PASC.
The intended outcome of the research funded by this grant opportunity is to improve the health and wellbeing of Australians by:
- Stream 4 (Aim 3 of Research Plan; Incubator and Targeted Call for Research): accelerating the identification of optimal management approaches for people living with PASC.
This grant opportunity is being administered by NHMRC on behalf of the Australian Government Department of Health and Aged Care.
Further information on the MRFF is available from the Department of Health and Aged Care.
